Pharmacokinetics of cefquinome following multiple doses intramuscular administration in goats using HPLC

Faculty	Veterinary Medicine	Year:	2016
Type of Publication:	ZU Hosted	Pages:
Authors:	Staff Zu Site Abstract In Staff Site
Journal:	Japanese Journal of Veterinary Research 64 (Supplement 2), S109-S115 Hokkaido University	Volume:

Keywords :	Pharmacokinetics , cefquinome following multiple doses intramuscular
Abstract:	Pharmacokinetics of cefquinome was investigated in goats following multiple IM doses (2mg/Kg) for 3 successive days using HPLC. The plasma concentration time data was best fitted by two compartment model demonstrating the presence of absorption, distribution and elimination phases. The maximum plasma concentrations (Cmax) following multiple IM administration were 3.66±0.03, 4.46±0.12 and 5.16±0.14 attained at Tmax of 2 hours and declined to (Cmin) 0.5±0.04 , 0.7±0.03 and 0.86±0.04 μg/ml at 24 h post drug administration in the first , second and third days respectively. Cefquinome was eliminated with half-life values (t o.5 el) of 6.13±0.54, 7.26±0.31 and 7.52±0.65 h in the first, second and third days post IM administration respectively. Cefquinome had a slight cumulative effect following repeated intramuscular administration and the repeated intramuscular injection of cefquinome at a dose of 2mg/kg with 24 h interval met pharmacokinetic–pharmacodynamic criteria predicting a successful therapy for susceptible bacteria with MIC ≤ 0.39 μg /mL.

Author Related Publications

Gamal Amer Salem Amer, "45- Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: Alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of SMO, GLI-1, and PTCH-1 genes.", Elsevier, 2023 More
Tariq Khamis Kamal Ahmed Khamis, "45- Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: Alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of SMO, GLI-1, and PTCH-1 genes.", Elsevier, 2023 More
Azza Ahmed Abdelghafar Gala, "Anti-arthritic effect of β-caryophyllene and its ameliorative role on methotrexate and/or leflunomide-induced side effects in arthritic rats", Elseiver, 2019 More
Sawan Mohamed Mohamed Ali Elsheakh , "Anti-arthritic effect of β-caryophyllene and its ameliorative role on methotrexate and/or leflunomide-induced side effects in arthritic rats", Elseiver, 2019 More
Abdelaleem Fouad Abdelaleem Ahmmid , "Anti-arthritic effect of β-caryophyllene and its ameliorative role on methotrexate and/or leflunomide-induced side effects in arthritic rats", Elseiver, 2019 More